Introduction: The HIV epidemic in Nepal is mainly concentrated among key populations, including people who inject drugs, gay men and other men who have sex with men, transgender people, female sex workers, and male labor migrants and their spouses. In countries with this type of concentrated HIV epidemic, the size of the key population estimation is important to address the national epidemic. Objectives: The study has been designed to estimate the district and national level size of key populations at risk of HIV infection and providing a foundation for policy and programing and to guide the national response to address HIV epidemic. Methods: This is a prospective mapping exercise study done in 44 districts of Nepal. Semi-structured interview were carried out among key populations members as well as non-key population key informants who were familiar with the local situation in and around the high prevalence areas. The study was conducted from August until November 2016. The collected data has been complied on Census and Survey Processing System and analyzed using Statistical Package for the Social Science software package 16 version. Results: The national estimates of key populations were FSW around 54,207, MSM/MSW/TG around 112,150 of which men having sex with men were 67,292. The PWID individuals range around 34,487. Conclusion: To fast track the response to achieve global 90-90-90 targets for the continuum of prevention to care, the country is updating its understanding of key population sizes and risk behaviors in different geographical area.
5 March 2021 in Scholars International Journal of Obstetrics and Gynecology
Summary points: In 2015, a survey-based analysis across 16 sub-Saharan African countries estimated that nearly half of people living with HIV were undiagnosed, implying ~11 million people in the region were outside the treatment cascade. However, HIV self-testing (HIVST), a technology effectively positioned to close this gap, was deployed at negligible scale for a decade following WHO recommendation in 2016. The gap has narrowed, but through conventional testing rather than HIVST, and 2.6 million people in sub-Saharan Africa and 4.9 million globally still did not know their HIV status in 2025. The decade of delay carries a likely avoidable burden of millions of illnesses, deaths and onward transmissions, though this has not been formally modelled. The need for HIVST in low- and middle-income countries was estimated at 177 million self-tests in 2020, rising to 192 million by 2025. Confirmed procurement over the same period reached only 21 million kits in total, an average of 5.3 million per year, or 3% of estimated annual need. Four interlocking structural failures explain this missed opportunity: 1) research capture through demonstration projects that substituted for population-scale deployment; 2) the early supervised self-testing paradox in which provider-assisted delivery reconstituted the clinic barriers HIVST was designed to bypass; 3) procurement conservatism that suppressed market development; and 4) an accountability failure with no publicly accessible Africa-level volume series, making the scale of the missed opportunity impossible to measure from published data. Four actions could improve access: 1) mandatory public reporting of HIVST commodity volumes; 2) a dedicated Africa-specific distribution target of at least 50 million kits per year within the UNAIDS 95-95-95 framework; 3) community-based distribution as the default model for the general population; and 4) explicit HIVST volume commitments in the GHSD’s 2026–2030 memoranda of understanding and work plans.